We are live on
!
Find out more
Loomis, Sayles & Company Portfolio holdings
AUM
$74.3B
1-Year Est. Return
24.01%
This Fund
S&P 500
This Quarter
Est. Return
+21.9%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$57.6B
AUM Growth
+$7.69B
(+15%)
Cap. Flow
+$3.7B
Cap. Flow
% of AUM
6.42%
Top 10 Holdings %
Top 10 Hldgs %
40.22%
Holding
1,054
New
202
Increased
277
Reduced
473
Closed
81
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bank of America Series L
BAC.PRL
|
+$3.4B |
| 2 |
Wells Fargo 7.5% Non Cumv Perp Conv
WFC.PRL
|
+$885M |
| 3 |
Tesla
TSLA
|
+$252M |
| 4 |
Amazon
AMZN
|
+$156M |
| 5 |
CLVT.PRA
Clarivate Plc 5.25% Series A Mandatory Convertible Preferred Shares
CLVT.PRA
|
+$144M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Novartis
NVS
|
+$379M |
| 2 |
Sherwin-Williams
SHW
|
+$161M |
| 3 |
NVIDIA
NVDA
|
+$154M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
+$116M |
| 5 |
Boeing
BA
|
+$80M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.6% |
| 2 | Consumer Discretionary | 15.59% |
| 3 | Communication Services | 15.36% |
| 4 | Healthcare | 13.38% |
| 5 | Financials | 10.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ONL
851
Orion Office REIT
ONL
$156M
| $7K | ﹤0.01% |
+1,100
| New | +$8.94K |
|
852
Quanta Services
PWR
$99.4B
| $7K | ﹤0.01% |
+40
| New | +$6.15K |
|
853
RB Global
RBA
$17.4B
| $7K | ﹤0.01% |
+128
| New | +$7.55K |
|
854
Amcor
AMCR
$21.8B
| $6K | ﹤0.01% |
99
-732
| -88% | -$41.9K |
|
855
Biogen
BIIB
$30.6B
| $6K | ﹤0.01% |
+20
| New | +$5.53K |
|
856
BILL Holdings
BILL
$4.91B
| $6K | ﹤0.01% |
71
-3,350
| -98% | -$311K |
|
857
BWX Technologies
BWXT
$15.5B
| $6K | ﹤0.01% |
+99
| New | +$5.97K |
|
858
Corteva
CTVA
$51B
| $6K | ﹤0.01% |
98
-137
| -58% | -$8.37K |
|
859
Fair Isaac
FICO
$22.7B
| $6K | ﹤0.01% |
+9
| New | +$5.99K |
|
860
Genuine Parts
GPC
$18.5B
| $6K | ﹤0.01% |
35
-523
| -94% | -$88.1K |
|
861
H&R Block
HRB
$5.82B
| $6K | ﹤0.01% |
157
-241
| -61% | -$8.91K |
|
862
Grand Canyon Education
LOPE
$3.82B
| $6K | ﹤0.01% |
+52
| New | +$5.86K |
|
863
Lamb Weston
LW
$7.12B
| $6K | ﹤0.01% |
62
-118
| -66% | -$11.7K |
|
864
PACCAR
PCAR
$69.1B
| $6K | ﹤0.01% |
79
-775
| -91% | -$55.5K |
|
865
PG&E
PCG
$37.5B
| $6K | ﹤0.01% |
+369
| New | +$5.83K |
|
866
Progressive
PGR
$124B
| $6K | ﹤0.01% |
40
-359
| -90% | -$49.5K |
|
867
Silgan Holdings
SLGN
$4.35B
| $6K | ﹤0.01% |
104
-681
| -87% | -$35.9K |
|
868
White Mountains Insurance
WTM
$5.04B
| $6K | ﹤0.01% |
4
-23
| -85% | -$33K |
|
869
ADT
ADT
$5.49B
| $5K | ﹤0.01% |
683
+427
| +167% | +$3.48K |
|
870
APA Corp
APA
$14.4B
| $5K | ﹤0.01% |
135
-209
| -61% | -$8.39K |
|
871
Ionis Pharmaceuticals
IONS
$9.46B
| $5K | ﹤0.01% |
146
-198
| -58% | -$7.43K |
|
872
M&T Bank
MTB
$36.3B
| $5K | ﹤0.01% |
41
-334
| -89% | -$48.5K |
|
873
Novavax
NVAX
$1.3B
| $5K | ﹤0.01% |
763
+638
| +510% | +$5.87K |
|
|
EXE
874
Expand Energy Corp
EXE
$22.6B
| $5K | ﹤0.01% |
63
-90
| -59% | -$7.41K |
|
|
MRO
875
DELISTED
Marathon Oil Corporation
MRO
| $5K | ﹤0.01% |
214
-435
| -67% | -$11.1K |
|
Similar funds
CBU
BC
Loomis, Sayles & Company's Q1 2023 Portfolio in Review
As of Q1 2023, Loomis, Sayles & Company held 1,054 positions worth $57.6B, up 15% from $49.9B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Loomis, Sayles & Company deployed $3.7B of net new capital in Q1 2023, opening 202 new positions and adding to 277 existing holdings. Its largest new stake was Bank of America Series L: 2,835,020 shares worth $81.1M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Communication Services.
On the sell side, the largest reduction was Novartis, an estimated $379M trimmed.
- Loomis, Sayles & Company's largest Q1 2023 buy was Bank of America Series L: 2,835,020 shares worth $81.1M.
- Loomis, Sayles & Company added most to Tesla in Q1 2023, an estimated $252M increase.
- Loomis, Sayles & Company's biggest Q1 2023 reduction was Novartis, cutting an estimated $379M.
- Loomis, Sayles & Company fully exited Globus Medical in Q1 2023, selling an estimated $38M.
- Loomis, Sayles & Company's ten largest holdings make up 40% of its $57.6B portfolio in Q1 2023.
- Loomis, Sayles & Company opened 202 new positions and closed 81 in Q1 2023.
- Loomis, Sayles & Company's portfolio value rose 15% quarter-over-quarter to $57.6B.
Based on Loomis, Sayles & Company's 13F filing for Q1 2023, filed 11 May 2023.